表紙
市場調查報告書

藥物釋放型球囊市場(各產品:冠狀動脈塗藥氣球,外周藥物釋放型球囊,各藥物塗料技術:Paccocath,FreePac,TransPax,EnduraCoat) - 全球產業分析,規模,佔有率,成長,趨勢,預測(2018∼2026年)

Drug Eluting Balloon Market (Product - Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon; Drug Coating Technology - Paccocath, FreePac, TransPax, EnduraCoat) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

出版商 Transparency Market Research 商品編碼 763022
出版日期 內容資訊 英文 212 Pages
商品交期: 最快1-2個工作天內
價格
藥物釋放型球囊市場(各產品:冠狀動脈塗藥氣球,外周藥物釋放型球囊,各藥物塗料技術:Paccocath,FreePac,TransPax,EnduraCoat) - 全球產業分析,規模,佔有率,成長,趨勢,預測(2018∼2026年) Drug Eluting Balloon Market (Product - Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon; Drug Coating Technology - Paccocath, FreePac, TransPax, EnduraCoat) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
出版日期: 2018年10月30日內容資訊: 英文 212 Pages
簡介

本報告提供全球藥物釋放型球囊市場相關調查,提供市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊。

第1章 序論

第2章 假設和調查方法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 概要
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
  • 市場分析與預測
    • 市場收益預測

第5章 市場預測

  • 法律規章方案
  • 心血管疾病罹患率
  • 主要的合併·收購
  • 主要的市場趨勢

第6章 各產品類型市場分析與預測

  • 簡介·定義
  • 主要調查結果/趨勢
  • 市場價值預測
    • 冠狀動脈塗藥氣球
    • 外周藥物釋放型球囊
    • 其他
  • 市場魅力度

第7章 藥物塗料各技術市場分析與預測

  • 簡介·定義
  • 主要調查結果/趨勢
  • 市場價值預測
    • Paccocath
    • FreePac
    • TransPax
    • EnduraCoat
    • 其他
  • 市場魅力度

第8章 各終端用戶市場分析與預測

  • 簡介·定義
  • 主要調查結果/趨勢
  • 市場價值預測
    • 醫院,門診外科中心
    • 導管實驗室
    • 其他
  • 市場魅力度

第9章 各地區市場分析與預測

  • 主要調查結果
  • 市場價值預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力度

第10章 美國市場

第11章 歐洲市場

第12章 亞太地區

第13章 南美

第14章 中東·非洲

第15章 競爭環境

  • 競爭矩陣
  • 市場佔有率分析
  • 競爭商務策略
  • 企業簡介
目錄

Title:
Drug Eluting Balloon Market (Product - Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon; Drug Coating Technology - Paccocath, FreePac, TransPax, EnduraCoat) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Drug Eluting Balloon Market - Overview

This report studies the current as well as future prospects of the global drug eluting balloon market. Stakeholders of this report include companies and intermediaries engaged in the manufacturing, commercialization, and provision of e eluting balloons and new players planning to enter the market. The report comprises an elaborate executive summary, along with a market snapshot, providing overall information on various segments considered in the scope of the study. The section also provides information and data analysis of the global drug eluting balloon market in terms of product, drug coating technology, end-user, and region.

The global drug eluting balloon market has been segmented based on product, drug coating technology, end-user, and region. In terms of product, the global market has been classified into coronary drug eluting balloons, peripheral drug eluting balloons, and others. The others segment comprises renal and urology drug eluting balloons. Based on drug coating technology, the market has been divided into Paccocath, FreePac, TransPax, EnduraCoat, and others. The others segment includes the proprietary drug coating technology of BD, Bioshell coating matrix, Biotronik specific coating, and Unicoat. Based on end-user, the global drug eluting balloon market has been segmented into hospitals and ambulatory surgical centers, CATH labs, and others. Hospitals and ambulatory surgical centers is expected to propel the global drug eluting balloon market during the forecast period.

Bottom-up approach has been employed for determining the size of the global drug eluting balloon market, using various market indicators obtained from secondary sources, which include analysis of launched products and mapping of sale of drug eluting balloon of top market players in specific regions. Top-down approach has been used to derive the market size of different product segments, wherein revenue of all publicly listed market players was obtained through secondary sources and analyzed for sales by narrowing down to revenue percentage for product segment through extensive analysis of annual reports, investor presentations, press releases, primary interviews, and others. Data triangulation is based on both secondary research (top-down and bottom- up approaches) and primary research. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. Market size and forecast, in terms of US$ Mn, for each segment has been provided for the period of 2016 to 2026. The report also provides compound annual growth rate (CAGR) in percentage for each segment for the forecast period, i.e. from 2018 to 2026, considering 2017 as the base year.

The market overview section of the report explores market dynamics, such as, drivers, restraints, opportunities, and key trends that have significant impact on the global drug eluting balloon market and may influence it in the near future. Market attractiveness analysis has been provided to explain the intensity of competition in the market across geographic regions. Competitive scenario existing among the market players has been evaluated through market share analysis in the competitive landscape section of the report. These analyses are likely to help market players take strategic decisions to strengthen their positions and grow their share in the global drug eluting balloon market. The report also comprises price comparison analysis, major mergers & acquisitions, reimbursement scenario by region/global market, overview of clinical trials, patent landscape, and epidemiological overview of cardiovascular diseases, key market trends, value chain analysis, and Porter's five forces analysis.

In terms of region, the global drug eluting balloon market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGR for the forecast period, i.e. from 2018 to 2026, considering 2017 as the base year. The report also provides market size and forecast for major countries in the above mentioned regions. A detailed qualitative analysis of factors responsible for driving and restraining the market and growth opportunities has been provided in the overview section. Competitive landscape section of the report provides analysis of market share of key players, thereby presenting a thorough analysis of the overall competitive scenario in the global drug eluting balloon market.

Major players operating in the global drug eluting balloon market are Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc, and Biotronik.

The global drug eluting balloon market has been segmented as follows:

Global Drug Eluting Balloon Market, by Product Type

  • Coronary Drug Eluting Balloon
  • Peripheral Drug Eluting Balloon
  • Others

Global Drug Eluting Balloon Market, by Drug Coating Technology

  • Paccocath
  • FreePac
  • TransPax
  • EnduraCoat
  • Others

Global Drug Eluting Balloon Market, by End-user

  • Hospitals and Ambulatory Surgery Centers
  • CATH Labs
  • Others

Global Drug Eluting Balloon Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Drug Eluting Balloon Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Drug Eluting Balloon Market Analysis and Forecast, 2016-2026
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

  • 5.1. Reimbursement Scenario
  • 5.2. Cardiovascular Disease Prevalence
  • 5.3. Key Mergers & Acquisitions
  • 5.4. Key Market Trends

6. Global Drug Eluting Balloon Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product Type, 2016-2026
    • 6.3.1. Coronary Drug Eluting Balloon
    • 6.3.2. Peripheral Drug Eluting Balloon
    • 6.3.3 Others
  • 6.4. Market Attractiveness, by Product Type

7. Global Drug-Eluting Balloon Market Analysis and Forecast, by Drug Coating Technology

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Drug Coating Technology, 2016-2026
    • 7.3.1. Paccocath
    • 7.3.2. FreePac
    • 7.3.3. TransPax
    • 7.3.4. EnduraCoat
    • 7.3.5. Others
  • 7.4. Market Attractiveness, by Drug Coating Technology

8. Global Drug Eluting Balloon Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2016-2026
    • 8.3.1. Hospitals & Ambulatory Surgical Centers
    • 8.3.2. Cath Labs
    • 8.3.3. Others
  • 8.4. Market Attractiveness, by End-user

9. Global Drug Eluting Balloon Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness, by Country/Region

10. North America Drug Eluting Balloon Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2016-2026
    • 10.2.1. Coronary Drug Eluting Balloon
    • 10.2.2. Peripheral Drug Eluting Balloon
    • 10.2.3. Others
  • 10.3. Market Value Forecast, by Drug Coating Technology, 2016-2026
    • 10.3.1. Paccocath
    • 10.3.2. FreePac
    • 10.3.3. TransPax
    • 10.3.4. EnduraCoat
    • 10.3.5. Others
  • 10.4. Market Value Forecast, by End-user, 2016-2026
    • 10.4.1. Hospitals & Ambulatory Surgical Centers
    • 10.4.2. Cath Labs
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2016-2026
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Drug Coating Technology
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Drug Eluting Balloon Market Analysis and Forecast

  • 11.1.Introduction
    • 11.1.1. Key Findings
  • 11.2.Market Value Forecast, by Product Type, 2016-2026
    • 11.2.1. Coronary Drug Eluting Balloon
    • 11.2.2. Peripheral Drug Eluting Balloon
    • 11.2.3 Others
  • 11.3.Market Value Forecast, by Drug Coating Technology, 2016-2026
    • 11.3.1. Paccocath
    • 11.3.2. FreePac
    • 11.3.3. TransPax
    • 11.3.4. EnduraCoat
    • 11.3.5. Others
  • 11.4.Market Value Forecast, by End-user, 2016-2026
    • 11.4.1. Hospitals & Ambulatory Surgical Centers
    • 11.4.2. Cath Labs
    • 11.4.3. Others
  • 11.5.Market Value Forecast, by Country/Sub-region, 2016-2026
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6.Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Drug Coating Technology
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Drug Eluting Balloon Market Analysis and Forecast

  • 12.1.Introduction
    • 12.1.1. Key Findings
  • 12.2.Market Value Forecast, by Product Type, 2016-2026
    • 12.2.1. Coronary Drug Eluting Balloon
    • 12.2.2. Peripheral Drug Eluting Balloon
    • 12.2.3. Others
  • 12.3.Market Value Forecast, by Drug Coating Technology, 2016-2026
    • 12.3.1. Paccocath
    • 12.3.2. FreePac
    • 12.3.3. TransPax
    • 12.3.4. EnduraCoat
    • 12.3.5. Others
  • 12.4.Market Value Forecast, by End-user, 2016-2026
    • 12.4.1. Hospitals & Ambulatory Surgical Centers
    • 12.4.2. Cath Labs
    • 12.4.3. Others
  • 12.5.Market Value Forecast, by Country/Sub-region, 2016-2026
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6.Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Drug Coating Technology
    • 12.6.3. By End-user
    • 12.6.4. By Country

13. Latin America Drug Eluting Balloon Market Analysis and Forecast

  • 13.1.Introduction
    • 13.1.1. Key Findings
  • 13.2.Market Value Forecast, by Product Type, 2016-2026
    • 13.2.1. Coronary Drug Eluting Balloon
    • 13.2.2. Peripheral Drug Eluting Balloon
    • 13.2.3 Others
  • 13.3.Market Value Forecast, by Drug Coating Technology, 2016-2026
    • 13.3.1. Paccocath
    • 13.3.2. FreePac
    • 13.3.3. TransPax
    • 13.3.4. EnduraCoat
    • 13.3.5. Others
  • 13.4.Market Value Forecast, by End-user, 2016-2026
    • 13.4.1. Hospitals & Ambulatory Surgical Centers
    • 13.4.2. Cath Labs
    • 13.4.3. Others
  • 13.5.Market Value Forecast, by Country/Sub-region, 2016-2026
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6.Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Drug Coating Technology
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Drug-Eluting Balloon Market Analysis and Forecast

  • 14.1.Introduction
    • 14.1.1. Key Findings
  • 14.2.Market Value Forecast, by Product Type, 2016-2026
    • 14.2.1. Coronary Drug Eluting Balloon
    • 14.2.2. Peripheral Drug Eluting Balloon
    • 14.2.3 Others
  • 14.3.Market Value Forecast, by Drug Coating Technology, 2016-2026
    • 14.3.1. Paccocath
    • 14.3.2. FreePac
    • 14.3.3. TransPax
    • 14.3.4. EnduraCoat
    • 14.3.5. Others
  • 14.4.Market Value Forecast, by End-user, 2016-2026
    • 14.4.1. Hospitals & Ambulatory Surgical Centers
    • 14.4.2. Cath Labs
    • 14.4.3. Others
  • 14.5.Market Value Forecast, by Country/Sub-region, 2016-2026
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Israel
    • 14.5.4. Rest of Middle East & Africa
  • 14.6.Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Drug Coating Technology
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1.Market Player - Competition Matrix (by Tier and Size of companies)
  • 15.2.Market Share Analysis, by Company (2017)
  • 15.3. Competitive Business Strategies
  • 15.4. Company Profiles
    • 15.4.1. Bayer AG
      • 15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.1.2. Product Portfolio
      • 15.4.1.3. SWOT Analysis
      • 15.4.1.4. Strategic Overview
      • 15.4.1.5. Financial Overview
    • 15.4.2. Medtronic
      • 15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.2.2. Product Portfolio
      • 15.4.2.3. SWOT Analysis
      • 15.4.2.4. Strategic Overview
      • 15.4.2.5. Financial Overview
    • 15.4.3. B. Braun Melsungen AG
      • 15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.3.2. Product Portfolio
      • 15.4.3.3. SWOT Analysis
      • 15.4.3.4. Strategic Overview
      • 15.4.3.5. Financial Overview
    • 15.4.4. Cook Medical, Inc.
      • 15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.4.2. Product Portfolio
      • 15.4.4.3. SWOT Analysis
      • 15.4.4.4. Strategic Overview
      • 15.4.4.5. Financial Overview
    • 15.4.5. Boston Scientific Corporation
      • 15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.5.2. Product Portfolio
      • 15.4.5.3. SWOT Analysis
      • 15.4.5.4. Strategic Overview
      • 15.4.5.5. Financial Overview
    • 15.4.6. Becton, Dickinson and Company
      • 15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.6.2. Product Portfolio
      • 15.4.6.3. SWOT Analysis
      • 15.4.6.4. Strategic Overview
      • 15.4.6.5. Financial Overview
    • 15.4.7. EuroCor
      • 15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.7.2. Product Portfolio
      • 15.4.7.3. SWOT Analysis
      • 15.4.7.4. Strategic Overview
      • 15.4.7.5. Financial Overview
    • 15.4.8. Terumo Corporation
      • 15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.8.2. Product Portfolio
      • 15.4.8.3. SWOT Analysis
      • 15.4.8.4. Strategic Overview
      • 15.4.8.5. Financial Overview
    • 15.4.9. Koninklijke Philips N.V
      • 15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.9.2. Product Portfolio
      • 15.4.9.3. SWOT Analysis
      • 15.4.9.4. Strategic Overview
      • 15.4.9.5. Financial Overview
    • 15.4.10. Other Prominent Players
      • 15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.10.2. Product Portfolio
      • 15.4.10.3. SWOT Analysis
      • 15.4.10.4. Strategic Overview
      • 15.4.10.5. Financial Overview

List of Tables

  • Table 1: Key Mergers and Acquisitions on Drug Eluting Balloon
  • Table 2: Snapshot of Ongoing Research on Drug Eluting Balloon
  • Table 3: Recent Patents on Drug Eluting Balloon
  • Table 4: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 5: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
  • Table 6: Global Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 7: Global Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Region, 2016-2026
  • Table 8: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country, 2016-2026
  • Table 9: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 10: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
  • Table 11: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 12: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 13: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 14: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
  • Table 15: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 16: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 17: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 18: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
  • Table 19: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 20: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 21: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 22: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
  • Table 23: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 24: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region,
  • Table 25: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 26: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
  • Table 27: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026

List of Figures

  • Figure 1: Global Drug Eluting Balloon Market Size (US$ Mn) and Distribution, by Geography, 2017 and 2026
  • Figure 2: Global Drug Eluting Balloon Market (US$ Mn), by Key Segment, 2017
  • Figure 3: Global Drug Eluting Balloon Market (US$ Mn), by Key Segment and Market Share (%), 2017
  • Figure 4: Global Drug Eluting Balloon Market (US$ Mn), by Market Share (%), 2017
  • Figure 5: Global Drug Eluting Balloon Market (US$ Mn), by Region (%), 2017
  • Figure 6: Global Drug Eluting Balloon Market Opportunity Map, by Product Type
  • Figure 7: Global Drug Eluting Balloon Market Opportunity Map, by Drug Coating Technology
  • Figure 8: Global Drug Eluting Balloon Market Opportunity Map, by End-user
  • Figure 9: Key Industry Evolution/Developments
  • Figure 10: Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 11: Global Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026
  • Figure 12: Global Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026
  • Figure 13: Coronary Drug Eluting Balloon Segment
  • Figure 14: Peripheral Drug Eluting Balloon Segment
  • Figure 15: Others Segment
  • Figure 16: Global Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026
  • Figure 17: Global Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026
  • Figure 18: Paccocath Segment
  • Figure 19: TransPax Segment
  • Figure 20: FreePac Segment
  • Figure 21: EnduraCoat Segment
  • Figure 22: Others Segment
  • Figure 23: Global Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026
  • Figure 24: Global Drug Eluting Balloon Market Attractiveness, End-user 2018-2026
  • Figure 25: Hospitals and ASCs Segment
  • Figure 26: CATH Labs segment
  • Figure 27: Others Segment
  • Figure 28: Global Drug Eluting Balloon Market Value Share, by Region, 2017 and 2026
  • Figure 29: Global Drug Eluting Balloon Market Attractiveness, Region
  • Figure 30: North America Drug Eluting Balloons Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 31: North America Drug Eluting Balloon Market Value Share, by Country, 2017 and 2026
  • Figure 32: North America Drug Eluting Balloon Market Attractiveness, by Country, 2018-2026
  • Figure 33: North America Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026
  • Figure 34: North America Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026
  • Figure 35: North America Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026
  • Figure 36: North America Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026
  • Figure 37: North America Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026
  • Figure 38: North America Drug Eluting Balloon Market Attractiveness, by End-user, 2018-2026
  • Figure 39: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 40: Europe Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 41: Europe Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 42: Europe Drug Eluting Balloons Market Value Share, by Product Type, 2017 and 2026
  • Figure 43: Europe Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026
  • Figure 44: Europe Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026
  • Figure 45: Europe Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026
  • Figure 46: Europe Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026
  • Figure 47: Europe Drug Eluting Balloon Market Attractiveness, by End-user, 2018-2026
  • Figure 48: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 49: Asia Pacific Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 50: Asia Pacific Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 51: Asia Pacific Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026
  • Figure 52: Asia Pacific Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026
  • Figure 53: Asia Pacific Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026
  • Figure 54: Asia Pacific Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026
  • Figure 55: Asia Pacific Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026
  • Figure 56: Asia Pacific Drug Eluting Balloon Market Attractiveness, by End-user, 2018-2026
  • Figure 57: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 58: Latin America Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 59: Latin America Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 60: Latin America Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026
  • Figure 61: Latin America Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026
  • Figure 62: Latin America Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026
  • Figure 63: Latin America Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026
  • Figure 64: Latin America Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026
  • Figure 65: Latin America Drug Eluting Balloon Market Attractiveness, by End-user, 2018-2026
  • Figure 66: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 67: Middle East & Africa Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 68: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 69: Middle East & Africa Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026
  • Figure 70: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026
  • Figure 71: Middle East & Africa Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026
  • Figure 72: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026
  • Figure 73: Middle East & Africa Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026
  • Figure 74: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by End-user, 2018-2026